Related Experiment Videos
[Heart patient with depressive disorder. Proper treatment method]
1Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum Münster. arolt@uni-muenster.de
MMW Fortschritte Der Medizin
|October 5, 2001
Summary
Depression is a significant risk factor for cardiac mortality after myocardial infarction. Treating depressive symptoms is crucial for patient well-being, even if direct cardiac benefits are not yet proven.
Area of Science:
- Cardiology
- Psychiatry
- Psychosomatic Medicine
Context:
- Depressive disorders are recognized as a significant independent risk factor for cardiac mortality, particularly following myocardial infarction.
- The association between depressive symptoms and coronary heart disease also warrants attention.
- Current understanding highlights the complex interplay between mental health and cardiovascular outcomes.
Purpose:
- To emphasize the importance of treating depressive disorders in patients with or at risk of heart disease.
- To review available treatment options for depression in this context.
- To underscore the need for continued research into the cardiac impact of depression.
Summary:
- Mild and severe depressive disorders independently increase the risk of cardiac mortality post-myocardial infarction and potentially in coronary heart disease.
- Treatment of depressive symptoms is recommended, irrespective of empirically demonstrated effects on cardiac status.
- Therapeutic options include selective serotonin re-uptake inhibitors, other pharmacological agents, brief psychotherapy, and social support enhancement.
Impact:
- Highlights the critical need for integrated care addressing both mental and physical health in cardiovascular patients.
- Informs clinical practice regarding the management of depression in myocardial infarction survivors.
- Suggests avenues for future research on the direct impact of depression treatment on cardiac outcomes.